Pulished Date August, 2019
ID: 227
Share on
Share on

North America Insulin Delivery Devices Market By Type (Insulin Syringes, Insulin Pens, Insulin Pumps), Application (Type I Diabetes & Type II Diabetes) - Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2018 To 2023)

Pulished: August, 2019
ID: 227
Pages: 135

North America Insulin maintains sugar levels in the blood and essential for the people suffering from type I diabetes & type II diabetes. The development of insulin delivery devices has been encouraged from the past years. These devices are used to deliver the insulin doses via parenteral route rather than oral route of administration. Insulin delivery devices promote absorption rate of insulin into blood stream from the site of injection to execute immediate pharmacological action of insulin. Some of the majorly used insulin delivery devices such as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors.

North America insulin delivery devices market is expected to reach USD 4.94 billion by 2023 from USD 6.54 billion in 2018, growing at a CAGR of 5.80% during the forecast period 2018-2023.

Growing number of obese population, increasing healthcare expenditure, rising number of diabetes patients, availability of medical reimbursements for human insulin pens in the U.S., and presence of more number of market players are driving the growth of insulin delivery devices market in North America. However, stringent regulatory laws for the product approval and low penetration rate of advanced insulin delivery devices in this region are restraining the growth of insulin delivery devices market in North America.

North America insulin delivery devices market is segmented based on the type and application. Based on type, the market is further sub-segmented as insulin syringes, insulin pens, insulin pen needles, insulin pumps, and insulin jet injectors. Of these, insulin syringes commanded the largest share of North America insulin delivery devices market in 2018, whereas insulin pens segment is estimated to grow at the highest CAGR during the forecast period 2018-2023. Based on application, the market is segmented as type I diabetes and type II diabetes.

On the basis of geographical areas, North America insulin delivery devices market is segmented as U.S., and Canada. U.S., accounted for larger share of the North America insulin delivery devices market in 2018, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2018-2023.

The key players in insulin delivery devices market such as, Becton, Dickinson and Company (U.S.), Sanofi (France), Novo Nordisk A/S (Denmark), Julphar (U.A.E.), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Ypsomed AG (Switzerland), Wockhardt Ltd. (India), B. Braun Meselgen AG (Switzerland), and Biodel Inc. (U.S.).

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Introduction                                                                               

                5.2 Type                                                                              

                                5.2.1 Introduction                                                           

                                5.2.2 Insulin Syringes                                                     

                                5.2.3 Insulin Pens                                                            

                                5.2.4 Insulin Pen Needles                                                            

                                5.2.5 Insulin Pumps                                                        

                                5.2.6 Insulin Jet Injectors                                                             

                5.3 Application                                                                 

                                5.3.1 Introduction                                                           

                                5.3.2 Type I Diabetes                                                     

                                5.3.3 Type II Diabetes                                                    

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Sanofi (France)                                                                         

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Novo Nordisk A/S (Denmark)                                                                             

                8.3 Eli Lilly and Company (U.S.)                                                                  

                8.4 Biocon Ltd. (India)                                                                   

                8.5 Julphar (U.A.E.)                                                                        

                8.6 Ypsomed AG (Switzerland)                                                                  

                8.7 Becton, Dickinson and Company (U.S.)                                                                          

                8.8 Wockhardt Ltd. (India)                                                                           

                8.9 B. Braun Meselgen AG (Switzerland)                                                                              

                8.10 Biodel Inc. (U.S.)                                                                    

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 


                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Insulin Delivery Devices Market By Region, From 2018-2023 (USD Billion)
  2. North America Insulin Delivery Devices Market By Type, From 2018-2023 (USD Billion)
  3. North America Insulin Syringes Market By Region, From 2018-2023 (USD Billion)
  4. North America Insulin Pens Market By Region, From 2018-2023 (USD Billion)
  5. North America Insulin Pen Needles Market By Region, From 2018-2023 (USD Billion)
  6. North America Insulin Pumps Market By Region, From 2018-2023 (USD Billion)
  7. North America Insulin Jet Injectors Market By Region, From 2018-2023 (USD Billion)
  8. North America Insulin Delivery Devices Market By Application, From 2018-2023 (USD Billion)
  9. North America Type I Diabetes of Insulin Delivery Devices Market By Region, From 2018-2023 (USD Billion)
  10. North America Type II Diabetes of Insulin Delivery Devices Market By Region, From 2018-2023 (USD Billion)
  11. United States Insulin Delivery Devices Market By Type, From 2018-2023 (USD Billion)
  12. United States Insulin Delivery Devices Market By Application, From 2018-2023 (USD Billion)
  13. Canada Insulin Delivery Devices Market By Type, From 2018-2023 (USD Billion)
  14. Canada Insulin Delivery Devices Market By Application, From 2018-2023 (USD Billion)

Please wait. . . . Your request is being processed


$ 1234 3335

Click for Request Sample